HPA001656
antibody from Atlas Antibodies
Targeting: ZNF148
BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001656 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001656, RRID:AB_1079995
- Product name
- Anti-ZNF148
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ZNF148, Gene description: zinc finger protein 148, Alternative Gene Names: BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148, Validated applications: ChIP, ICC, IHC, Uniprot ID: Q9UQR1, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway
Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
Zfp148 Deficiency Causes Lung Maturation Defects and Lethality in Newborn Mice That Are Rescued by Deletion of p53 or Antioxidant Treatment
Zou Z, Gul N, Lindberg M, Bokhari A, Eklund E, Garellick V, Patel A, Dzanan J, Titmuss B, Le Gal K, Johansson I, Tivesten Å, Forssell-Aronsson E, Bergö M, Staffas A, Larsson E, Sayin V, Lindahl P
Scientific Reports 2020;10(1)
Scientific Reports 2020;10(1)
Genetic predisposition to B-cell acute lymphoblastic leukemia at 14q11.2 is mediated by a CEBPE promoter polymorphism.
Studd JB, Yang M, Li Z, Vijayakrishnan J, Lu Y, Yeoh AE, Paulsson K, Houlston RS
Leukemia 2019 Jan;33(1):1-14
Leukemia 2019 Jan;33(1):1-14
Zfp148 Deficiency Causes Lung Maturation Defects and Lethality in Newborn Mice That Are Rescued by Deletion of p53 or Antioxidant Treatment
Deb S, Sayin V, Nilton A, Ibrahim M, Ågren P, Larsson E, Petit M, Hultén L, Ståhlman M, Johansson B, Bergo M, Lindahl P
PLoS ONE 2013;8(2):e55720
PLoS ONE 2013;8(2):e55720
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- ChIP-Exo-Seq composite graph for Anti-ZNF148 (HPA001656, Lot A115722) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.